⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2010Journal of Korean Endocrine SocietyOpen Access

Recent Developments of Anti-diabetic Agents Undergoing 2 and 3 Phase Clinical Trials

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

최근

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jung Guk Kim (2010) studied this question.

synapsesocial.com/papers/6ab47f7436ef184be74dd6ac https://doi.org/10.3803/jkes.2010.25.1.18

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Glucose Transporter and Na+ / glucose Cotransporter as Molecular Targets of Anti-Diabetic DrugsOriginal Research · 2004 · 72 citations
2Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar TreatmentOriginal Research · 2008 · 68 citations
3Biochemical and physiological function of stearoyl-CoA desaturaseOriginal Research · 2008 · 742 citations
4Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessonsClinical Trial · 2005 · 244 citations
5Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ AgonistRisk Assessment · 2007 · 42 citations

More related papers

Active sugar transport in health and disease2007
Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor2008

More from Journal of Korean Endocrine Society

Acromegaly with Diabetes Insipidus after Pituitary Tumor Removal: Successful Pregnancy and DeliveryFri,
Secondary Pituitary Hyperplasia Induced by Hashimoto's Thyroiditis Related Hypothyroidism: A Case ReportFri,
A Case of Primary Hyperparathyroidism with Rapid Regression of a Brown Tumor after ParathyroidectomyFri,